↓ Skip to main content

PLOS

Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men

Overview of attention for article published in PLOS ONE, March 2014
Altmetric Badge

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
80 Mendeley
Title
Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men
Published in
PLOS ONE, March 2014
DOI 10.1371/journal.pone.0091513
Pubmed ID
Authors

Julia L. Marcus, David V. Glidden, Vanessa McMahan, Javier R. Lama, Kenneth H. Mayer, Albert Y. Liu, Orlando Montoya-Herrera, Martin Casapia, Brenda Hoagland, Robert M. Grant

Abstract

In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the effect of daily oral emtricitabine/tenofovir (FTC/TDF) PrEP on HSV-2 seroincidence and ulcer occurrence among men who have sex with men (MSM) in the iPrEx trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Brazil 2 3%
Unknown 76 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 15%
Student > Master 12 15%
Professor 8 10%
Student > Bachelor 8 10%
Other 5 6%
Other 16 20%
Unknown 19 24%
Readers by discipline Count As %
Medicine and Dentistry 26 33%
Nursing and Health Professions 4 5%
Social Sciences 4 5%
Psychology 4 5%
Agricultural and Biological Sciences 3 4%
Other 13 16%
Unknown 26 33%